Emilia Pardal

987 total citations
13 papers, 276 citations indexed

About

Emilia Pardal is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Emilia Pardal has authored 13 papers receiving a total of 276 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Genetics and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Emilia Pardal's work include Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Emilia Pardal is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Radiomics and Machine Learning in Medical Imaging (2 papers). Emilia Pardal collaborates with scholars based in Spain, Italy and United Kingdom. Emilia Pardal's co-authors include Alejandro Martı́n, Marı́a Dolores Caballero, María‐Victoria Mateos, Sara Alonso, M Navarro, Ramón García‐Sánz, Magdalena Sierra, Jesús F. San Miguel, Eva González‐Barca and Santiago Montes‐Moreno and has published in prestigious journals such as Blood, American Journal Of Pathology and British Journal of Haematology.

In The Last Decade

Emilia Pardal

12 papers receiving 269 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Emilia Pardal Spain	8	99	79	73	73	54	13	276
Kazutaka Takagi Japan	9	213 2.2×	35 0.4×	26 0.4×	66 0.9×	114 2.1×	26	357
Bruce A. Silver United States	8	117 1.2×	33 0.4×	83 1.1×	34 0.5×	75 1.4×	15	296
Kendall W Cradic United States	11	203 2.1×	76 1.0×	34 0.5×	34 0.5×	83 1.5×	19	492
Guowei Dai China	9	268 2.7×	28 0.4×	55 0.8×	156 2.1×	68 1.3×	18	451
Eugenio Lucia Italy	11	122 1.2×	48 0.6×	120 1.6×	125 1.7×	76 1.4×	48	290
Michael Leisch Austria	9	115 1.2×	20 0.3×	54 0.7×	78 1.1×	72 1.3×	14	273
Matthew Clement United States	5	155 1.6×	57 0.7×	144 2.0×	83 1.1×	94 1.7×	5	467
Sara Nunnery United States	8	158 1.6×	44 0.6×	34 0.5×	47 0.6×	115 2.1×	15	352
Hidenobu Kamohara Japan	11	216 2.2×	22 0.3×	17 0.2×	45 0.6×	147 2.7×	24	467
Yang He China	11	162 1.6×	22 0.3×	15 0.2×	75 1.0×	58 1.1×	32	361

Countries citing papers authored by Emilia Pardal

Since Specialization

Citations

This map shows the geographic impact of Emilia Pardal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emilia Pardal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emilia Pardal more than expected).

Fields of papers citing papers by Emilia Pardal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emilia Pardal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emilia Pardal. The network helps show where Emilia Pardal may publish in the future.

Co-authorship network of co-authors of Emilia Pardal

This figure shows the co-authorship network connecting the top 25 collaborators of Emilia Pardal. A scholar is included among the top collaborators of Emilia Pardal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emilia Pardal. Emilia Pardal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Buduo, Christian A. Di, Vittorio Abbonante, Pedro Ruiz‐Sala, et al.. (2022). Novel variants in GALE cause syndromic macrothrombocytopenia by disrupting glycosylation and thrombopoiesis. Blood. 141(4). 406–421. 11 indexed citations

Hernández‐Sánchez, María, Teresa González, Miguel Quijada‐Álamo, et al.. (2022). TRAF3 alterations are frequent in del‐3′IGH chronic lymphocytic leukemia patients and define a specific subgroup with adverse clinical features. American Journal of Hematology. 97(7). 903–914. 5 indexed citations

Torrelo, Antonio, Mercedes Gironella, Emilia Pardal, et al.. (2021). Mastocytosis in the skin accompanied by pseudo‐Kaposi’s sarcoma. The Journal of Dermatology. 48(5). 657–660.

Bergesio, Fabrizio, Emilia Pardal, Xavier Setoaín, et al.. (2020). The 18 F phantom clinical trials qualification for 18F-FDG-PET scanning adopted by GELTAMO (Grupo Español de Linfomas/Trasplante Autologo de Médula Ósea). Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 40(3). 149–154. 2 indexed citations

Ramón, Cristina De, José‐Ángel Hernández‐Rivas, José Antonio Rodríguez García, et al.. (2020). Impact of Sars-CoV2 Infection on 491 Hematological Patients: The Ecovidehe Multicenter Study. Blood. 136(Supplement 1). 5–6. 7 indexed citations

Alonso, Sara, Emilia Pardal, M Navarro, et al.. (2017). Plitidepsin: design, development, and potential place in therapy. Drug Design Development and Therapy. Volume11. 253–264. 80 indexed citations

Pardal, Emilia, Alejandro Martı́n, Carlos Grande, et al.. (2014). Intensification treatment based on early FDG‐PET in patients with high‐risk diffuse large B‐cell lymphoma: a phase II GELTAMO trial. British Journal of Haematology. 167(3). 327–336. 31 indexed citations

Rubio, Montserrat López, Javier Loscertales, Enrique Colado, et al.. (2013). Hairy cell leukemia treated initially with purine analogs: a retrospective study of 107 patients from the Spanish Cooperative Group on Chronic Lymphocytic Leukemia (GELLC). Leukemia & lymphoma. 55(5). 1007–1012. 16 indexed citations

González‐Porras, José Ramón, Fernando Escalante, Emilia Pardal, et al.. (2013). Safety and efficacy of splenectomy in over 65‐yrs‐old patients with immune thrombocytopenia. European Journal Of Haematology. 91(3). 236–241. 47 indexed citations

10.

Sebastián, Elena, Miguel Alcoceba, Ana Balanzategui, et al.. (2012). Molecular Characterization of Immunoglobulin Gene Rearrangements in Diffuse Large B-Cell Lymphoma. American Journal Of Pathology. 181(5). 1879–1888. 29 indexed citations

11.

Pardal, Emilia, Fátima De la Cruz, Carlos Panizo, et al.. (2012). Prognostic Value of Interim PET/CT in Patients with Poor Risk Diffuse Large B-Cell Lymphoma (DLBCL). Experience of the Spanish Geltamo Group. Blood. 120(21). 5076–5076. 1 indexed citations

12.

Paiva, Bruno, María‐Belén Vídriales, José J. Pérez, et al.. (2011). The clinical utility and prognostic value of multiparameter flow cytometry immunophenotyping in light-chain amyloidosis. Blood. 117(13). 3613–3616. 46 indexed citations

13.

Olivier, C, et al.. (1996). [Pelvic Castleman's disease: apropos of a case].. PubMed. 41(3). 241–3. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact